Latest News & Features
Patents
The Unified Patent Court (UPC) opened for business in June 2023. In this session, we will look at how UPC litigation has been shaping up over the last year, including practical tips based on our experiences so far. 29 October 2024
Patents
The patent landscape for biologics, biosimilars, and advanced therapeutic antibodies is undergoing rapid change, presenting both opportunities and challenges for innovators and manufacturers. This panel will explore current issues and strategies in this dynamic field. 29 October 2024
Patents
Korean pharmaceutical, biotech, and life sciences companies are actively expanding globally, leading to more complex and multifaceted IP strategies than in the past. 29 October 2024
Patents
Join us as we delve into the complexities of international harmonization and global patent strategies in the ever-evolving landscape of IP rights. 29 October 2024
Patents
The dynamic landscape of patent law is continually influenced by evolving regulations and legal decisions, and one of the key areas at the forefront of these changes is the Patent Trial and Appeal Board (PTAB). 29 October 2024
Patents
How to foster effective collaboration between academia and industry?
Best practices for bridging that gap between the two spheres
Technology transfer
How to leverage academic research for commercialization 29 October 2024
Patents
The integration of cutting-edge medical technology within the life sciences has ushered in an era of unprecedented innovation, transforming the landscape of healthcare and patient wellbeing. 29 October 2024
Patents
Obviousness-type double patenting can pose a significant challenge, as it can lead to unfair extensions of patent rights, and limit other’s abilities to build upon inventions, hindering further innovation. 29 October 2024
Patents
In today's global marketplace, intellectual property (IP) rights are not merely legal tools but strategic assets that can significantly influence a product's lifecycle, from development to market. 29 October 2024
Patents
On January 10 this year, the director of the USPTO issued new guidelines on enablement under 35 U.S.C §112. In recent years, the landscape of patent law in the United States has undergone a significant shift, with courts adopting a more stringent stance on the criteria of enablement and written description. 29 October 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.